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INTRODUCTION 
Managing preterm labour is a challenging aspect of Perinatal 
Medicine. Preterm labour is a significant factor affecting perinatal 
outcomes, in terms of complications and mortality. Preterm labour is the 
onset of labour before 37 weeks of gestation birth, where the threshold of 
viability is between 22 and 26 weeks (according to British Association of 
Perinatal Medicine), thus preterm labour occurs between 22-26 weeks 
and 37 weeks gestation. Preterm births contributes largely to infant 
mortality rate. It is one of the challenging fields in obstetrics and many 
new tests and drugs are under trial to improve the outcomes of preterm 
labour. 
 
Preterm delivery constitutes about 11% births in U.S and more in 
developing countries. Preterm delivery is on the raise due to medical 
complications, increase in assisted reproductive techniques, stress and 
other reasons. Infant mortality rate also depends on the period of 
gestation when preterm labour occurs. 
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In the developed world most hospitals are well equipped with neonatal 
care for preterm infants. In developing countries like India neonatal  
support for preterm infants are yet to be opened in most hospitals. This 
warrants an early and correct diagnosis of preterm labour and timely 
referral to higher centres for preterm care and avoid unnecessary 
referrals. Preterm birth continues to be a leading cause of neonatal 
morbidity and mortality. Absence of a reliable screening method to 
confirm preterm labour is another challenging factor. 
 
Cervicovaginal phosphorylated insulin-like growth factor binding 
protein-1 (phIGFBP-1) is one of the major proteins of the decidualised 
endometrium. Concentration in the amniotic fluid is 100 to 1000 times 
higher than that in the serum. Amniotic fluid contains the non-
phosphorylated form and the lesser phosphorylated form. Decidua is 
abundant in phosphorylated insulin-like growth factor binding protein-1 a 
highly phosphorylated isoform of IGFBP-1.It is detected in 
cervicovaginal secretions before the onset of labour due to the 
detachment of the foetal membranes from the decidua. 
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 Cervicovaginal detection of phIGFBP-1has been proposed as a 
reliable predictor of impending preterm delivery. 
This study aims to evaluate the prediction of preterm labour with the 
detection of cervical phosphorylated insulin like growth factors. 
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LITERATURE REVIEW 
 
DEFINITIONS 
Preterm Labour 
WHO defines Preterm labour as ―the commencement of regular 
uterine contractions, between viability and 37 weeks of gestation, along 
with cervical effacement and dilatation. 
Threshold of viability 
Preterm delivery before 26 weeks or babies weighing less than 750 
gm are at the current threshold of viability according to ACOG 2002, 
2008 and suffer from many problems like medical, social. According to 
American Academy of Paediatrics current guidelines it is not necessary to 
resuscitate infants born prior to 23 weeks or those weighing less than 400 
gm. Infants born at 22, 23, 24, or 25 weeks are considered to be under 
threshold due to immature organ systems. These infants are at higher risk 
for ischemic brain injuries as active brain development occurs during 
second and third trimester. 
       According to Tyson and associates (2008) factors improving the 
prognosis of preterm infants at the threshold of viability were singleton 
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pregnancy, female gender, steroids given for foetal lung maturation, and 
higher gestational age. 
In 2008 Mc Intire and Leveno reported that idiopathic natural 
preterm labour or premature tear of membranes constituted 80% of late 
preterm births and the rest of 20% was constituted by complications like 
hypertension, placental abnormalities.  
 
REASONS FOR PRETERM DELIVERY 
About 40-45% of preterm labour occurs spontaneously and 30% 
because of rupture of membranes (preterm) , and the rest 30-35% are 
induced preterm labours. One of the major reasons for preterm include 
multiple pregnancies. Etiology of preterm labour is multifactorial. Some 
of the factors attributing to preterm are:- 
 Delivery for maternal or fetal indications 
 Idiopathic preterm premature rupture of membranes 
 High order births 
 Uterine anomalies 
 Foetal anomalies 
 Genital tract infections 
 Placental causes 
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 Foetal causes 
 Unexplained reasons 
 
 
 
Delivery for maternal or foetal indications: 
Indicated preterm delivery is done for various reasons. One third of 
preterm delivery is iatrogenic indicated for maternal or foetal reasons. 
These include: 
Maternal causes 
• Preeclampsia 
• Placenta previa 
• Abruption 
• Chronic hypertension 
• Diabetes 
• Renal disease 
• Cardiac disease 
 
Foetal causes 
• Foetal distress 
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• Severe foetal growth restriction due to utero placental 
insufficiency 
• Rh iso immunisation 
• Severe oligohydramnios 
• Congenital malformation. 
 
Idiopathic preterm premature rupture of membranes 
Preterm rupture of membranes may occur due to reduction of 
membrane strength or due to increased intrauterine pressure theoretically. 
The amniotic membranes is a connective tissue and any defect in 
synthesis, degradation or collagen quality can result in preterm rupture of 
membranes. 
High order births 
Multiple gestation constitutes about 12-15% of all preterm births. 
Multiple gestations cause over distention of uterus resulting in initiation 
of preterm labour, infection, preterm rupture of membranes.Early 
activation of CRH and the physiological pathway for parturition,and over 
distention mechanical force leading to activation of protein kinase 
Mitogen –activated protein kinases and increased expression of G 
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proteins that induce myometrium contractility are the proposed 
mechanisms of preterm labour. 
 
Uterine Anomalies 
Congenital anatomical abnormalities of uterus and cervix are seen 
in 1-3% of preterm births. They occur due to mullerian ducts defect and 
septate and bicornuate uterus are clinically significant. The rate of 
preterm delivery in these patients range about 16-20%. Overdistention of 
uterus caused by multiple gestation, polyhydramnios also contribute to 
preterm labour. 
Cervical Abnormalities 
About 5 % of preterm births are due to anatomical or physiological 
abnormalities of cervix. These include women exposed to 
diethylstilboestrol during intrauterine period, who had conisations or 
cervical surgeries. 
Genital tract infections 
Infection is one of the most common cause of preterm labour and 
responsible for 20-40% of all preterm cases. The most accepted 
mechanism is ascending infection. This theory suggests an occurrence of 
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break in the normal physiological barrier present between the vaginal 
flora and the products of conception. The vaginal bacteria ascend through 
the breech and colonise the decidua and chorion and then enters the 
amniotic fluid and the foetus. This is supported by the fact that organisms 
secluded from the amniotic fluid and the vagina are similar. The vaginal 
flora is separated by the cervix and the cervical mucus plug. Cervical 
changes and changes in mucus plug contribute to ascending infection. 
Common organisms include Chlamydia, group B streptococcus, 
trichomonas, Gonococcus. Repeated pelvic examination during 
pregnancy and sexual intercourse are also implicated. 
According to Goldenberg and colleagues (2008b) these intrauterine 
infections trigger the innate immune system and activate preterm labour. 
These organisms initiate the release of inflammatory cytokines like 
tumour necrosis factor and interleukins which stimulates prostaglandins 
production which leads to uterine contractions there by leading to preterm 
labour. 
Intra uterine infections – Chorioamnionitis 
 Acute chorioamnionitis diagnosis is clinical and is diagnosed by 
the presence of fever and 2 of the following features maternal or foetal 
tachycardia, bad smell of amniotic fluid, maternal leucocytosis, and 
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uterine tenderness. Labour in these patients occur as a protective 
mechanism. 
Subclinical chorioamnionitis is an infection of the conceptus 
without clinical signs or symptoms of the disease. This condition occurs 
in preterm labour with ruptured membranes or incompetent cervix. 
Patients with      subclinical chorioamnionitis present with uterine 
contractions. The diagnosis is by amniotic fluid analysis for Gram stain, 
white cell count, concentrations of interleukin 6, glucose, lactate 
dehydrogenase and cultures. The most common organisms isolated are 
Urea plasma urealyticum, Mycoplasma hominis, Fusobacterium species 
and Gardenella vaginalis. 
The leukocyte count in amniotic fluid analysis WBC >12,000/mm3 
or or left shift or bandemia (>9%) suggests chorioamnionitis. 
Concentration of glucose in amniotic fluid is also used as a method to 
diagnose chorioamnionitis. The best marker for chorioamnionitis is IL-6 
concentration of greater than 7.9ng/ml in patients with ruptured 
membranes and more than 11.39 ng/ml in patients with intact membranes. 
 
Extra uterine infections 
Bacteria may acquire contact to the lower pole of the uterus though 
a normally functioning cervix, because of an increased number of virulent 
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pathogens in the vagina, where they activate inflammatory mediators that 
leads to cervical ripening and shortening. Many criteria and tests have 
been followed to diagnose bacterial vaginosis 
 
1.  Spiegel’s criteria 
Normal: Gram stain shows a predominance of Lactobacillus acidophilus 
(3+ or 4+), with or without Gardenella vaginalis 
Bacterial vaginosis: Gram stain shows absent or decreased Lactobacillus 
acidophilus (zero to 2+) and mixed flora (gram-positive, gram-negative 
or gram-variable bacteria). 
Lactobacillus acidophilus (large gram-positivebacilli) 
Gardnerella vaginalis (small gram-variable rods)  
Counting for the above bacterial morphotypes 0 = No morphotypes per 
oil-immersion field 
1+ = Less than one morphotypes per oil-immersion field 
2+ = One to five morphotypes per oil-immersion field 
3+ = Six to 30 morphotypes per oil-immersion field 
4+ = More than 30 morphotypes per oil-immersion field 
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2.  Amsel’s diagnostic criteria 
o Thin, homogeneous discharge 
o Vaginal pH > 4.5 three of four criteria must be met to 
diagnose bacterial vaginosis 
o Positive ―whiff‖ test 
o ―Clue cells‖ located on microscopy (highly significant 
criterion) 
3.  Nugent’s criteria 
Based on the examination of the four bacterial morphotypes, the 
interpretation of the Gram stain was interpreted based on a standardised 
criteria by Nugent et. al. It is the assessment of relative concentration of 
bacterial morphotypes characteristics of altered flora. According to 
Nugent‘s criteria, a score of 4-10, indicates abnormal vaginal flora.  
According to Romero et al. (1988) 5-10% of preterm labour 
patients have an infection outside the uterus. Urinary tract infections also 
cause preterm labour. These infections provoke the synthesis of 
production of interleukins and TNF by the macrophages which in turn 
cause prostaglandin synthesis by the amnion which result in preterm 
labour. About 25% of patients with preterm labour have a urine analysis 
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suggestive of urinary tract infection. Group B streptococcus infection of 
the urinary tract has been related to preterm labour. The occurence of 
preterm labour has been reduced in patients treated against group B 
streptococcus infection.  
Asymptomatic bacteriuria association with preterm labour is 
controversial (Kaaset al.1970). As reported by Romero et al., 1989 
evidence support a relationship between asymptomatic bacteriuria and 
preterm labour. 
Gingivitis is also associated with preterm labour (Jeffcoat et al., 
2001) .The bacteria found in periodontal disease and those in placental 
culture of preterm labour patients are found to be similar. These bacteria 
spread through haematogenous route and colonise the uterus resulting in 
preterm labour. Contractility are the proposed mechanisms of preterm 
labour. 
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INFECTIONS ASSOCIATED WITH PRETERM DELIVERY 
 
GENITAL  
Bacterial Vaginosis (BV) 
Group B streptococcus 
Chlamydia 
Mycoplasmas 
 
INTRAUTERINE  
Ascending (from genital tract) 
Trans placental (blood-borne) 
Trans fallopian (intraperitoneal) 
Iatrogenic (invasive procedures) 
 
EXTRAUTERINE 
Pyelonephritis 
Malaria 
Typhoid fever 
Pneumonia 
Listeria 
Asymptomatic bacteriuria 
 
Placental causes 
 Abnormal placentation 
 Anatomical  abnormalities 
 Placenta praevia 
 Abruption placenta 
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Abnormal placentation 
Abnormal placentation has been implicated as one of the causes of 
preterm labour. Histological studies of placenta (Arias et al.,1993) in  
preterm labour shows some defect in spiral arteries development, spiral 
artery thrombosis, and the placenta are small and have calcifications, 
infarctions and fibrosis  . Decrease in uteroplacental flow causes foetal 
growth retardation and hence account for low birth infants in preterm 
labour(Lackman et al., 2001). Studies have shown that patients with 
Doppler abnormalities in early gestation have higher incidence of 
pretermlabour. Abnormal morphology, implantation, and functions of 
placenta also result in preterm labour. 
Anatomical abnormalities 
Marginal insertion of cord, battledore placenta, circumvallate 
placenta are also associated with preterm labour. 
Abruption placenta  
Placental Abruption is an abnormal premature separation of a 
normally implanted placenta. There are different kinds of abruption, 
based on the extent and region of separation. 
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Abruption of the placenta may lead to preterm labour, through the 
thrombin release, which encourages myometrial contractions by protease-
activated receptors. With placental abruption, there is no time for pre-
ripening of the uterine cervix to occur, hence the preterm labour with 
chorioamnionitis is mostly quick, whereas those with placental abruption, 
is less. (Phillip R.Bennet, 2011). 
Placenta Previa 
Placenta Previa can be defined as placenta inserted in wholly or partially 
in the lower uterine segment. This also causes preterm labour. 
Foetal causes 
Birth defects were associated in preterm deliveries according to 
Dolan and colleagues (2007). 
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EPIDEMIOLOGY 
RACE 
Preterm birth rates vary with different ethnicities and races. According to 
Goldenberg and colleagues in 2008 Black, African-American and Afro-
Caribbean have a higher risk of preterm birth. Recurrent preterm birth is 
seen in black women according to Kistka and Colleagues, 2007. 
 Gene in 1996 reported that the rate of pre-term birth in African 
American women (2000) was not influenced by social and demographic 
factors. 
AGE: 
Preterm birth is associated with parity and maternal age. Young 
multiparae and older primiparae have higher risks of preterm delivery. 
According to Lumley Jm et al 1993 the incidence of preterm delivery is 
high in mothers less than 17 and more than 35 yrs. Very young maternal 
age can contribute to preterm labour (Amini et al, 1996). According to 
Hediger et al, (1997) adolescent girls less than 16 years, have twice the 
risk of preterm labour considering with older women. At the other end, 
women aging 35 and over too higher preterm delivery risks (Astolfi and 
Zonna 2002) 
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WEIGHT 
Poor nutrition, pre pregnancy weight and weight gain during 
pregnancy play an important role in causing preterm labour. Hickly and 
colleagues in 2005 have reported that low maternal weight gain is often 
associated with preterm birth. 
STATURE 
Short statured women have tendencies to deliver small babies. 
According to Lao and Ho, 1997 indicated that preterm delivery and 
labour risks was more in teenage pregnancies, and the occurrence was 
conversely related with maternal height. This proposed that the 
characteristic risk of preterm delivery in teenagers was short stature, 
which in turn could have been a reflection of young physical 
development during pregnancy.  
SOCIOECONOMIC STATUS 
The reasons for socioeconomic differences in preterm births are not 
clear, and have not been much explored. A number of reasons like 
maternal nutrition, smoking, abuse, activities, work and prenatal care 
have been implicated with preterm births. Women from lower socio 
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economic status tends to be less educated and would not have satisfactory 
general, prenatal and antenatal care (Goffinet F 2005) 
Low socioeconomic status on health appears to directly affect the 
incidence of preterm labour (Moutquin, 2003). Many studies show an 
correlation between preterm birth and numerous socioeconomic issues 
like societal class, education, marital status, earnings. Maternal nutrition 
before and during pregnancy have contributed to the risk of preterm 
births, and this can be analysed by body mass index (WHO, 1995).  
ADDICTIONS 
Women who smoke and cocaine users are at increased risk of 
preterm labour (Bens 2004). The correlation between smoking and 
preterm birth was only existing among women with an increased intake 
of caffeine. Smoking more than 20 cigarettes per day has resulted in the 
increased incidence of pre-term birth under 34 week‘s gestation. Smoking 
initially associated with placental abruption, placenta praevia and pre 
mature rupture of membranes has now been linked with pre term delivery 
(Cnattingius 1998). Boer et al 1993, Volpe studied the increased 
incidence of pre-term birth in women addicted to opiods. Though, 
whether smoking alone effects the risk of preterm birth among heavy 
users of caffeine requires further investigation. 
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Studies show women who abuse cocaine have high incidence of 
preterm labour, and it was partly attributed to the abruption caused by 
cocaine addiction. (Boer et al) 
Studies relating consumption of alcohol with the risk of pre-term 
labour are very few. 
Occupational hazards 
Those involved in manual work are more prone for preterm labour 
 
PREDISPOSING FACTORS 
Stress: 
Preterm birth is associated with psychological factors such as 
depression, anxiety and chronic stress (Copper: 1996, Li 2008, Littleton 
2007).Occupation which involve heavy physical work and psychological 
strain are associated with increased preterm births (Papiernik and 
Kaninski 1994).The utero placental flow decreases in prolonged standing 
and increases the frequency of placental infarcts causing intrauterine 
growth retardation. Preterm birth is increased in women who are 
subjected to physical abuse. Henribon et al 1995 reported that heavy 
vigorous exercise in the third trimester increased the risk of pre-term 
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delivery while regular and moderate exercise were actually showing a 
reduced risk. 
Coitus 
Various theoretical mechanisms have been proposed for initiation 
of labour by sexual activity. These are nipple and genital stimulus may 
induce oxytocin release from the posterior pituitary, initiating uterine 
contractions. Prostaglandins that is released from mechanical stimulation 
of the cervix may be the reason of cervical ripening and prostaglandins in 
semen may also cause cervical ripening. Mills and co-workers found in 
singleton low-risk pregnancies sexual activity did not increase the 
frequency of preterm labour.  
The influence of sexual interaction on recurring preterm delivery in 
women with history of prior spontaneous preterm birth was studied by 
Yost and colleagues at less than 32 weeks‘ gestation and concluded that 
sexual intercourse had no effect on the occurrence of recurring preterm 
delivery. But the risk of recurrent preterm delivery increased with 
multiple sexual partners. 
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Reproductive History  
a) Previous preterm birth     
The risk of preterm delivery increases with a history of previous 
preterm delivery. Spong, 2007 concluded that previous preterm delivery 
was a major risk factor for preterm labour. 
History of one previous preterm birth is associated with a 
recurrence risk of 16-41 % (Williams 22‖‘ edition).Preterm delivery risks 
increases with the number of preterm birth and decreases with term 
deliveries. This risk is on an increasing trend whenever the number of 
prior preterm births increases (Hoffinan 1981). Women having a prior 
preterm delivery have three times the risk of recurrence compared to a 
woman who has got a previous term delivery. This risk increases to eight 
fold whenever there is a history of two preterm deliveries. Though 
preterm delivery is an important risk factor to recurrent preterm delivery, 
previous preterm birth contributes to only 10% of total preterm births 
(Bloom and associates 2001). Factors such as cervical length and inherent 
biological property of the cervix may contribute to the recurrence of 
preterm births. 
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b) Previous abortion 
Preterm deliveries increase in women who experienced one or 
more second trimester abortions. Earlier encouraged abortions were 
mainly linked with preterm delivery and the risk of preterm birth 
increased with the number of abortions. The extent of association with 
previous induced abortion varied according to the cause of preterm 
delivery. Prior encouraged abortions mainly increased preterm delivery 
risks after idiopathic preterm labour, preterm premature rupture of 
membranes and ante‐partum haemorrhage, but not preterm delivery after 
maternal hypertension. The strength of the correlation increased with 
decreasing gestational age at birth. 
c) Cervical incompetence 
Cervical Incompetence is diagnosed clinically by recurrent painless 
cervical dilation and spontaneous mid trimester abortions in the absence 
of membrane rupture, bleeding or infection. . This can lead to protrusion 
of the membranes into the vagina followed by expulsion of the immature 
foetus.  This may repeat in future pregnancies if not treated. 
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Some of the causes are previous traumatization of the cervix 
caused by 
 Dilatation and curettage 
 Conisation 
 Cauterisation 
 Amputation of cervix 
According to Albrechten and colleagues (2008) there is a fourfold 
risk of pregnancy loss before 24weeks in patients who had undergone 
cervical conisation. 
d) Uterine anomalies: 
e) Pregnancy complications 
 Multiple pregnanciesHydramnios 
 Preeclampsia 
 Antepartum hemorrhage 
 Second trimester bleeding not due to placental causes 
Interval between pregnancies 
Interval between pregnancies play a major role in preterm labour. 
Intervals shorter than 18 months and longer than 59 months has 
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beenconsidered as increased risk for preterm & small for gestational age 
infants (Conde - Agudelo 2006) 
Preterm births was increased if the interval between childbirth and 
LMP of next pregnancy was less than 3 months. Bloom et al in 2001 
found athreefold increase in risk if   previous birth was preterm compared 
to a previous term pregnancy. A previous occurrence of preterm birth 
before 34 weeks may increase the risk of recurrence. (Krymko et al 2004) 
Foetal Gender 
Male babies have an increased chance of preterm delivery 
compared to female babies.  
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PATHOGENESIS OF PRETERM LABOUR 
The normal labour involves three components namely cervical 
ripening, myometial and foetal membrane activation. Preterm labour can 
be physiological or pathological if it occurs prematurely ordue to an 
abnormal stimulus respectively. Though etiology of preterm labour is 
multifactorial infection is implicated in initiation of preterm labour. 
Withdrawal of progesterone theory established in parturition in 
sheep is not clear in humans. Increased synthesis of prostaglandins 
initiate parturition. 
The intrauterine tissues synthesise prostanoids which play an 
important role in the commencement or maintenance of labour in a 
number of species. The amnion during labour produces more amount of 
PGE2 (Mitchell, 1986; Casey and MacDonald, 1986), which stimulates 
the physiological process leading to birth. Though the stimulus for 
preterm labour varies the final pathway involves the inflammatory 
mediators cytokines. 
Cervical Ripening 
This involves transformation of firm long cervix to soft distendable 
cervix. Cervix is predominantly made up of connective tissue namely 
fibroblasts and extracellular matrix. At end of pregnancy, there is increase 
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in collagenase activity and hyaluronic acid production which decrease the 
collagen content and increase the water content of cervix. Sex steroids 
and prostaglandins are involved in initiation of parturition. 
Activation of foetal membranes 
During pregnancy, the chorioamnionic membranes fuse with the 
decidua. Many biochemical reactions occur in term and preterm labour 
which cause the separation of the foetal membranes from the decidua 
which results in rupture of membranes. Fibronectins are present at the 
chorionic-decidual interface which are degraded and released into 
cervical and vaginal secretions immediately before term and preterm 
parturition. Beyond proteolytic degradation of the decidual and 
amniochorionic extracellular matrix by matrix-degrading enzymes, 
PROM is also associated with amnion epithelial apoptosis and localized 
inflammation. Enzymatic activity of matrix proteases are involved in the 
process of rupture of membranes and parturition with intact membranes. 
Contraction of myometrium 
In pregnancy uterine contractions are inhibited by progesterone, 
relaxin, and nitricoxide. At the end of pregnancy these substances reduce 
making the uterus respond to uterotonic agents. Increase in intracellular 
concentration of calcium is implicated in uterine contractions. Though 
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uterine contractions play a vital role in preterm labour compared to 
cervical ripening or foetal membrane activation studies involving 
myometrial activity are limited. 
                  Prostaglandins    play an important role in   preterm labour. 
Csapo (1961) proposed that labour commenced when the balance 
between myometrial stimulants and relaxants is lost. Prostaglandin 
endoperoxide H synthase increases the rate first, committed step of 
prostaglandin synthesis from arachidonic acid (Smith et al, 1991). 
Prostaglandin endoperoxide H synthase activity increases in the amnion 
at parturition.  According to    DeWitt (1991) and Smith et al (1991), the 
prostaglandin endoperoxide H synthase expression is affected by various 
substances like growth factors, vascular cells, cytokines, steroids and 
tumour promoters in fibroblasts, and monocyte- and macrophage-like 
cells 
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CELL MEMBRANES 
 
Glycerphospholipids 
 
Arachidonic acid 
 
Prostaglandin H2 
 
PGE 2                                                                                         PGF2α 
 
 
CONTRACTION OF UTERUS 
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Role of Cytokines in Preterm labour 
Cytokines such as interleukin 1, 2, 6 and 8 and tumour necrosis 
factor are implicated in preterm labour. Infection is associated with by a 
host-inflammatory response, which causes accumulation of inflammatory 
cells in the chorioamnionic membranes and thereby increasing the 
expression of cytokines .This inflammatory process can trigger the onset 
of preterm labour by myometrial contractions, PPROM and cervical 
ripening. This is supported by the fact that there is an increased cytokine 
levels (e.g. interleukin-6 [IL-6] and IL-8) in the amniotic fluid of patients 
with preterm labour. Interleukin 1 and tumour necrosis factor cause 
rupture of foetal membranes. 
In Sweden a study conducted about the association between the 
intra-amniotic microbial colonisation and the levels of IL-6 and IL-8, and 
their association with preterm birth revealed that microorganisms in the 
amniotic fluid were detected in 16% of women in preterm birth and 25% 
of women with PPROM. It was also found that a high ratio of cases with 
preterm labour (43%) and PPROM (57%) hadraised IL-6 and or IL-8 
levels in the amniotic fluid, indicating an inflammatory response.  
Hence a solid relation between inflammation, microbialisation and 
preterm birth was established. Level of cytokines in amniotic fluid 
predicted preterm birth. 
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Interleukin-18 has also been found to play a major role in preterm 
labour. It is produced as a proform and is stimulated by the 
enzymecaspase-1. This in turn activates  intracellular signalling pathway 
through interface with the IL-18 receptor causing pro-inflammatory 
molecules, like interferon-g, tumour necrosis factor-a (TNF-a) and IL-
1.Hence IL-18 can  be considered  to play a vital  role in infection leading 
to  preterm birth. Levels of IL-18 seem to be raised in the cervical and 
amniotic fluid of women in preterm labour compared with those not in 
labour at term. 
 
DIAGNOSIS OF PRETERM LABOUR 
Cunningham Gil and co-workers (2001) found that preterm labour 
is established when regular uterine contractions occur at least 4 in 20 
minutes or 8 in 60 minutes with progressive change in cervical score with 
effacement 80% or more and dilatation more than 1 cm occurs. Preterm 
labour can be diagnosed by various factors .Preterm labour can be 
diagnosed by clinical methods and by investigations. 
Threatened preterm labour is a condition in which uterine 
contractions occur in the absence of cervical changes. 
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PAPIERNIK SCORING SYSTEM 
 
Points 
Socioeconomic 
factors 
Previous 
Obstetric 
/Medical 
History 
Social 
Aspects of 
current 
Pregnancy 
 
1 
 
Two living children 
low socioeconomic 
status 
H/o 1 abortion 
/ 
less than 1 
year of last 
child birth 
Employed 
Unusual 
fatigue 
 
2 
Maternal age <20 
or 
>40 years/single 
parent 
H/o 2 
abortions 
Smoker 10 
Cigarettes/ 
day/ moderate 
work 
Gain <5g by 
32 weeks 
 
 
3 
Very low 
socioeconomic 
status Ht< 150cm 
wt<45 kg 
H/o 3 abortion 
Heavy work / 
long distance 
traveling 
Breech 32 
weeks/ 
weight loss 
/head 
engaged at 
32 weeks / 
febrile 
illness 
 
 
4 
Maternal age <18 
year 
Pyelonephritis  
Bleeding 
after 12 
weeks / 
short cervix 
open 
internal OS 
uterine 
irritability 
 
 
5 
 
Uterine 
anomaly 
second 
trimester 
abortion /DES 
exposure/cone 
biopsy 
 
Placenta 
Praevia 
Hydramnios 
 
 
6 
 
Preterm 
delivery 
,repeated 
second 
trimester 
abortion 
 
Twins/ 
abdominal 
surgical 
procedure 
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SYMPTOMS 
 Menstrual like cramps 
 Low dull back ache 
 Increase or change in vaginal discharge 
 Uterine contractions 10 minutes apart or closer 
 
CLINICAL ASSESSMENT 
Uterine contractions 
Uterine contractions is the main symptom of preterm labour. There 
should be regular uterine contractions of at least 4 in 20 minutes or 8 in 
60 minute each lasting not less than 40 seconds. 
Uterine Activity Monitoring 
Although teaching a woman to self-monitor her uterine 
contractions is a simple inexpensive method, there are lot of subjective 
variations in it which makes it less reliable .The perception of the 
contractions in terms of frequency ,intensity, duration may vary between 
the health care providers hence a tocodynamometer can be used to assess 
the contractions. One of an earlier case control study reported a decrease 
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in the preterm delivery rates on using the ambulatory monitoring system. 
(Katz et al 1986). 
Current opinion is that for most patients home uterine monitoring 
is no better than frequent nursing care and support. Only patients, who 
cannot recognize the presence of uterine contractions adequately like 
multi foetal gestation and over distended uterus may benefit from home 
monitoring. 
These contractions are accompanied by progressive cervical 
changes. 
 
CERVICAL ASSESSMENT 
The clinical diagnosis of labour is dependent on the presence of 
uterine activity with cervical effacement and dilation. One of the main 
sign of term or preterm labour is cervical change. When patients come 
with the complaint of pain after confirming uterine contractions pelvic 
examination is done. The following features are assessed namely 
position, consistency, dilatation, effacement of the cervix. This digital 
examination is not precise as there are   inter- and intra-operator errors. 
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CERVICAL LENGTH 
Cervical length measurement by digital examination formed the 
gold standard for diagnosis of preterm labour. Women with shorter 
cervices experienced increased rates of preterm birth. 
The manual assessment of cervical length is subjective and has 
poor inter and intra observer variability. The cervix shortens and dilates at 
the level of internal cervical os. This process cannot be appreciated on a 
digital examination. Transvaginalultrasound examination of cervical 
length is better than digital examination in predicting preterm delivery. 
Hence cervical length measurement by ultrasound is used for prediction 
of labour. 
 The normal way of evaluating cervical length is by endo-vaginal 
ultrasound. Different measurements have been used to define short 
cervix. In patients with short cervical length, the ―T‖ that is seen in 
ultrasound of cervix becomes ―Y‖ and later on ―U‖ as the amniotic sac 
descends. Though the conclusion of a short cervix does not mean 
incompetence and it is only a proposal, and neither can it identify, the 
pathological reasons for it. Before 1994, the studies done were surveyed 
by cerclage, making it harder to confirm. Later Jams et al; 1994, reported 
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a means cervical length at 24 weeks around 35mm with progressively 
shorter cervix had more changes of preterm delivery.  
Owen and co-workers concluded in 2003 that the value of cervical 
length to predict birth before 35 weeks is apparent only in high risk 
patients for preterm delivery .Studies by De Caralto et al 2005correlated 
the cervical length to preterm delivery. Hassan et al 2000 & 2001, found 
that when the cervical length was less than 25 mm, there was a high 
chance of preterm delivery with the normal mean length of cervix at 23 
weeks of gestation being 35mm to 38 mm with the 10
th
 and 90
th
 
percentile being 25mm and 45mm respectively. 
A cervical length of 21mm at less than 20 weeks of gestation was 
shown by Cook et al (2000) to be associated with high risk preterm 
delivery. Owen et al (2001) showed at 3.3 time‘s higher risk for preterm 
delivery if the cervical length of 25 mm or less is seen at 16-19 weeks of 
pregnancy. An ultrasound screening every two weeks was also found to 
be significantly helpful (Andoers et al 2000). 
FUNNELING 
In women who are prone to deliver prematurely herniation of the 
foetal membranes occurs into the upper part of the endocervical canal.  
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Although the length, width and relationship of funnel to cervical 
length have been studied, there are no uniform criteria to describe 
funnelling. The reporting of funnelling as present or absent on ultrasound 
is a significant conclusion to be cited as its found equivalent to dynamic 
cervical changes. Rust et al (2005) showed the risk of preterm labour, 
higher incidence of complication and cerclage placement in women with 
both cervical shortening and funnelling. 
Dynamic cervical changes 
The opening of the internal os and descent of the foetal membranes 
on fundal pressure during ultrasound was found to be significant risk 
factor for preterm labour (Gwzman et al, 1994). Passive or dynamic 
ultrasound finding of shortening of the cervix between 15 and 22 weeks is 
a significant predictor of additional cervical shortening (Gwzman et al, 
1997). The myometrial activity in painless uterine contractions leads to 
dynamic changes and is an indication that that the cervix is opening 
during these contractions. 
Cervical dilatation 
A study by Papiemik and his colleagues (1987) on cervical status 
before 37 weeks, concluded that risk of preterm labour is increased by 
precocious cervical dilatation. According to Levino and associates, one in 
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four women who had dilated cervices (2-3cm) between 26 and 30 weeks, 
had their delivery before 34 weeks. Copper and associates (1995) have 
found that asymptomatic cervical dilation that occurs after mid pregnancy 
is significant preterm labour risk reason. Pereira and co-workers, (2007) 
identified cervical dilation as a predictor of a higher preterm delivery risk. 
 
 
CERVICAL INCOMPETENCE 
Premature cervical dilatation is associated with increased risk of 
preterm labour (Papiemik and colleagues 1987).In a study by Levino and 
associates one fourth of the women who cervices were dilated 2 to 3 cm 
between 26 and 30 weeks delivered before 34 weeks .Asymptomatic 
dilatation of cervix after mid trimester is considered as a risk factor for 
preterm labour. In a study by Cook and Ellwood. Cervical status of 
nulliparous and parous women between 18 and 30 weeks was followed 
up and both the groups gave birth to term. Copper and associates in 1995, 
Pereira and colleagues in 2007 have suggested cervical dilatation as an 
increased risk for preterm labour.  
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INVESTIGATIONS 
Foetal fibronectin 
Foetal fibronectin is produced in 20 different types of molecular 
forms by different kinds of cells. These includes hepatocycles, 
fibroblasts, endothelial cells and foetal amnion. Foetal fibronectin is 
found in high concentration in both maternal blood and amniotic fluid. 
They are thought to play an initial role in intercellular adhesion during 
implantation and in maintaining placental attachment to the exterior 
decidue according to Lesson and colleagues (1996). 
Foetal fibronectin is found in cervical secretions in term patients 
and normal patients with intact membranes. This denotes stromal 
remodelling of the cervix before labour. It is normally found in cervico 
vaginal secretions before 16-18 weeks gestation before the fusion of the 
foetal membrane to the decidual and then towards term prior to the onset 
of labour. It is usually not found between 22 and 37 weeks of gestation.  
Lockwood and co-workers in 1991 reported that fibronectin in 
cervicovaginal secretions can be considered as a marker for impending 
preterm labour. Swabs taken from posterior fornix or cervix is used for 
the detection of foetal fibronectin by ELISA method with FDG 6 
monoclonal antibody. Value exceeding 50 mg/ml is considered as 
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positive. Quantitative tests takes a longer time to develop, hence bedside 
tests have been developed. High false positive rates are there if sample is 
contaminated with amniotic fluid, semen, maternal blood, patients with 
encirclage. Goldberg and co- workers in 2000 reported detection of 
fibronectin in the vaginal or cervical secretions as an important predictor 
of preterm labour. 
Leitich and co-workers performed a comprehensive meta-analysis 
on the efficacy of foetal fibronectin in identifying women at risk for 
preterm delivery. They noted that the test's usefulness was a result of its 
high specificity and was limited by the low sensitivity in identifying 
women who would go on to deliver prior to 34 weeks gestation. The 
sensitivity of the test decreased further in identifying women who would 
deliver prior to 37 weeks but increased when it was used serially. 
In order to maximize foetal fibronectin, its use should be restricted 
to women with intact membranes, cervical dilation less than 3 cm, and 
gestational age between 24 and 34 completed week‘s gestation, and 
results should be available within 24 hours. False-positive foetal 
fibronectins may be obtained in women with recent intercourse or vaginal 
examinations or in the presence of bacterial vaginosis and vaginal 
bleeding. 
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In general, the sensitivity of foetal fibronectin increases in 
symptomatic women, women with a cervical length of less than 2.5 mm, 
women with a history of prior preterm delivery, and women with 
bacterial vaginosis. The negative predictive value in women with preterm 
contractions ranges from 69% to 92% before 37 weeks gestation. 
Importantly, a negative foetal fibronectin has a 95% likelihood that 
delivery will not occur within 14 days of sampling. 
The Preterm Prediction Study of the National Institute of Child 
Health and Human Development analysed the sensitivity, specificity and 
predictive values of Bishop Score, fibronectin test and cervical length in 
predicting preterm labour in asymptomatic women (Iams et al, 2001) 
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CERVICAL PHOSPHORYLATED INSULIN LIKE GROWTH 
FACTOR BINDING PROTEIN -1 
 
Diagnosis of preterm labour poses a major problem. Any test that 
can precisely diagnose preterm labour will be of much help. One of the 
latest modality in predicting preterm labour is phosphorylated insulin like 
growth factor binding protein -1 in cervical secretions. 
Insulin-like growth factor-binding protein 1 also known as 
placental protein 12 is a protein that in humans is encoded by the IGFBP1 
gene . The gene encoding for insulin like growth factor binding protein 1 
is localised on human chromosomal region 7 p14-p12. 
Insulin like growth hormone is a single chain polypeptide 70 amino 
acid residue, cross linked by three Disulphate Bridge. The Molecular 
weight is 7649.It is homologous to proinsulin; 1 to 29 are homologous to 
insulin B and 42-62 to insulin chain A. An octopeptide sequence at 
COOH terminal end is not found in proinsulin.  
 
Insulin like growth factor binding protein-1 belongs to a super 
family of insulin like binding protein. Insulin like growth factor of both 
type‘s l and ll are involved in the control mechanism of foetal placental 
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growth and development. Binding of this protein prolongs the half-life of 
the IGFs and alters their interaction with cell surface receptors.  Insulin 
like growth factor binding protein 1 is secreted from the adult and foetal 
liver. The maternal concentration of insulin like growth factor binding 
protein 1 increases as pregnancy advances and forms a major constituent 
of amniotic fluid from second trimester onwards. Its concentration in 
amniotic fluid is 100-1000 times higher than that found in the plasma. 
 
 
Insulin Growth Factor Binding Protein 
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There are six subtypes insulin like growth factor binding protein-1   
and the highly phosphorylated isoform is found in decidual tissues 
secreted the decidual cells. The non- phosphorylated and the lesser 
phosphorylated is form is found in amniotic fluid. The difference in the 
origin of insulin like growth factor can be detected with the use of 
monoclonal antibodies. During the process of labour, the 
choriodecidual interface is disrupted releasing the phosphorylated insulin 
like growth factor binding protein -1 into the cervical secretions. Bed side 
kits have been developed for the qualitative detection of phosphorylated 
insulin like growth factor binding protein -1 above 10mg/l. 
 
AMNIOCENTESIS TO DETECT INFECTION: 
There are several tests to analyse intra-amniotic infections. Tests 
done by Romero and his colleagues in 1993 in 120 women with intact 
membranes and preterm labour, were used to assess the value of amniotic 
fluid that had increased leukocyte counts, elevated interleukin -6 
concentration or a positive Gram stain, and reduced glucose level. 
Those results with positive amniotic fluid culture were counted as 
infected.  The experiments concluded that a negative Gram stain result 
was 99% to dismiss amniotic fluid bacteria. An increased value of 
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interleukin-6 level, was 82% sensitive for finding out amniotic fluids that 
has bacteria. 
There are other studies by Andrews and co-workers (1995) and 
Yoon and colleagues (1996) which have also proven that there exists a 
relation between the amniotic fluid inter leukin-6 levels (or leukocyte 
levels) and chorioamnio infections. Although these studies prove the 
relationship between the two, it is not confirmed that amniocentesis to 
identify infection is related with improved pregnancy results with or 
without rupture of membranes in women (Einstein and co-workers, 
1986).It is determined that there is no indication to support routine 
amniocentesis to detect infection. 
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OTHER BIOCHEMICAL MARKERS 
1. Salivary oestriol> 1.8/mi before 34 weeks has sensitivity of 
68% and specificity of 76% for preterm labour before 35 weeks 
of gestation(Darne et al) 
2. Serum collagenase 
3. Tissue inhibitor of metalloproteinase (TIMP)/Matrix 
metailoproteinases 
4. Relaxin 
5. Corticotrophin Releasing Hormone 
6. Human chorioniegonadotrophin 
These are of less practical value in prediction of preterm labour 
Mediators of Inflammation and Infection 
a. C — Reactive protein 
b. Granulocyte elastase 
c. Cytokines (IL-6, TNF) 
d. Amniotic Fluid Glucose Concentration 
e.Zinc 
f. Lipocortin -l (Romeo R et al) 
g. Positive cultures 
h. Granulocyte colony stimulating factor 
These are not practically helpful in prediction of pre-term labour. 
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MANAGEMENT OF PRETERM LABOUR 
The management of preterm labour includes 
 To prevent preterm onset of labor if possible 
 To arrest labor if not contraindicated 
 Appropriate management of labor 
 Neonatal care 
PREVENTION OF PRE TERM LABOUR 
Prevention is an important strategy in the management of a patient at high 
risk of preterm labour. The following guidelines are adopted: 
i)  Primary care 
Aimed to reduce incidence by reducing the high risk factors. 
ii)  Secondary care 
Screening for early detection and prophylactic treatment. 
iii)  Tertiary care 
Aimed to reduce the perinatal morbidity and mortality after the 
diagnosis. 
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Basic care 
Development of family support, education, supportive services 
from health care providers  
 Behavioural and life style modifications 
 Adequate nutrition. 
 Cessation of smoking (Burguet et al) 
 Avoidance of illicit drugs 
Bed rest, hydration and sedation 
Although bed rest and hydration are widely used as the first step of 
prevention, its practical benefit has been debatable. (Golden berg RL  
et al)  
Kovacevich et al in his studies showed that bed rest of more than 
three days was associated with an increased occurrence of 
thrombocmbolic events in women with threatened pre-term labour. 
Some studies have reported the increased risk of development of 
pulmonary edema, when intravenous fluids are administered during 
tocolytic therapy. There is no substantial evidence of hydration therapy in 
causing pregnancy prolongation. Hydration therapy however has been 
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rarely studied as a single therapy in prevention or treatment of pre-term 
labour. 
Cochrane systematic review showed no significant difference in 
the risk of pre-term labour in women who received hydration therapy. 
Comparative trials have been conducted between combination of sedation 
with hydration vs intramuscular opiods in reducing the occurrence of 
preterm delivery and the results were found to be similar in both groups. 
Treatment of infections 
About 25 — 40 percent of preterm births are estimated to result 
from intrauterine infections (Cunningham et al 2010) Morency and 
Buyold (2007) seemed to indicate that antibiotics given in the second 
trimester to females with a past of preterm labour would be effective in 
preventing reappearance of preterm labour 
Most Randomized control trials show that intra vaginal 
clindamycin cream used to treat bacterial vaginosis did not reduce the 
rate of preterm birth. Carey et al (2000) used oral metronidazole to treat 
bacterial vaginosis but did not find a reduction in preterm birth. 
Methodical evaluation determined that screening and treatment of 
asymptomatic bacteruria and bacterial vaginosis may lessen the 
occurrence of preterm in low risk population 
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Cervical encirclage 
Primary circlages are placed prophylactically in women considered 
at high risk of preterm birth based on obstetric history. Secondary 
circlages are placed when ultrasound findings are indicative of cervical 
insufficiency in high risk women. 
Tertiary circlages are done as an emergency process in the 
presence of positive clinical examination findings. The 1993 
MRC/RCOG Multicenter Randomized experiment determined that clear 
benefit was seen only in patients with a history of three or more 
spontaneous births or preterm deliveries (Mac Naughton et al 1993) 
In 2001, CIPRACT Trial, Cervical Incompetence Prevention 
Randomised Cerclage Trial showed that patients with cervical 
insufficiency and cerclage placement had a lower incidence of preterm 
delivery prior to 34 weeks (ALTHUISIUS ET AL 2001) 
Rest Ct al 2000 concluded that cerclage failed to alter any perinatal 
outcome Daskalakis et al (2006) reported the benefits of emergency 
cerclage. In preterm labour Dor et al 1982 and Roman et al 2005 reported 
that elective cerclage had no benefit in twin gestation. Two randomized 
trials by Lazr et al and Rush et al showed no benefit of routine cerclage in 
women at moderate risk for preterm labour. 
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EMERGENCY OR RESCUE CERCLAGE 
 There are certain studies that show that cervical incompetence and 
preterm labour together may lead to preterm delivery. Studies have 
analysed the importance of cerclage that is done after preterm labour 
initiates. If cervical incompetence is found with risk of preterm labour, 
emergency cerclage can be tried, although there is risks of pregnancy loss 
and infection (Harger, 1983). In an experiment conducted by Althuisius 
and his co-workers, among 23 women with cervical incompetence before 
27 weeks patients were subjected to bed rest with or without McDonald 
cerclage. The result was, that delivery delay was more in the group with 
cerclage than that of bed rest alone by 54 and 24 days respectively. 
 Another study was done by Terkildsen and his colleagues in 2003 
that included 116 women for whom second trimester emergency cerclage 
was attempted. Membranes that extended outside the external cervical os 
and cerclage before 22 weeks, were linked with substantial decreased 
occurrence of pregnancy continuance to 28 weeks or more. 
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Progesterone 
Progesterone given as weekly intramuscular injections of 17 
hydroxyl progesterone caproate from 16-20 weeks to 37 weeks showed 
significant decrease in preterm labour (Meis et al 2003) .It is not 
beneficial in twin pregnancies (Rouse et al 2007) (.Fonseca et al 2007) 
Micronized progesterone for asymptomatic women with very short cervix 
(Less than 15mm) appear to be effective for prevention of preterm 
delivery. 
As per AGOG (2008) progesterone is not recommended as a 
supplementary treatment to cervical cerclage for suspected cervical 
insufficiency or .as a preventive agent for asymptomatic women with a 
positive foetal fibronectin screen result or as a tocolytic agent. The role of 
progesterone in threatened preterm labour is uncertain (Cochrane 
Systematic Review 2006). 
Cortico steroids 
The potential for antenatal administered corticosteroids to 
accelerate lung maturity was discovered by Liggens. In 1995 National 
Institute of Health consensus Development Panel recommended 
corticosteroids for foetal lung maturation in preterm infants, antenatal 
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corticosteroids are recommended for all pregnant women between 25 and 
34 weeks who are at risk of preterm delivery within 7 days. 
The initial reason for the usage of steroids in women with preterm 
delivery risk, was to avoid neonatal respiratory distress syndrome. After 
analysing a number of steroids administered pregnant women, it was 
revealed that there was another important benefit, which was the 
prevention of neonatal IVH. As there are such significant benefits of 
steroids administration, that overcome most of the theories that object 
such an approach about steroid usage, strong reasons must be justified for 
not using this treatment, especially in cases when preterm labour is going 
to occur before 30 weeks. 
Cochrane systematic analysis reported that antenatal 
corticosteroids reduce neonatal death respiratory distress syndrome, intra 
ventricular haemorrhage, necrotizing enter colitis in first 48 hours of life 
as well as reduction in the need for intensive care monitoring & 
respiratory support later 
For women with established preterm labour, a mix of 
betamethasone acetate (6mg) and betamethasone phosphate (6mg) must 
be administered intramuscularly, in consecutive two doses, with 24 hours 
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interval, with no contraindications for steroids. Some even prefer to use 
dexamethasone 4mg IM, for four doses every six hours.  
Roberts and Daiziel (2006) reviewed antenatal corticosteroids for 
accelerating foetal lung maturity Bruschettini and colleagues (2006) 
studied equivalent of 12 mg versus 6 mg beta methadone and reported 
that the lower dose had less severe effects on somatic growth without 
affecting cell proliferation Eli main and co-workers (2007) reported that 
beta methasone and dexamethasone were comparable in reducing the 
rates of major neonatal mortalities in preterm infants. 
According to Crowley, 1995, proposes that the effect of 
glucocorticoids, on foetal lung lasts not more than one week, through 
meta-analysis of random clinical trials. After this finding, the practice of 
administration of booster dose of betamethasone for every week for those 
who remained undelivered seven or more days after the early treatment, 
was adopted by many obstetricians.  
 Nevertheless, there are evidences that such a practice is linked with 
major fetal and neonatal side-effects, and it should be abandoned (Debbs 
et al, 1997; Banks et al, 1999; Vermillion et al 1999, Jobe et al, 1998; 
French et al, 1999) 
61 
Though the maximum benefit of corticosteroid administration is 
between 24 hours and 7 days after initiation of therapy they provide 
surgical advantage even when baby is delivered within 24 hours. 
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RESCUE 
 Rescue means giving a repetitive dose of corticosteroid when 
delivery is about to happen and more than 7 days have passed from the 
time of the first dose. It is said that rescue therapy should not be 
repetitively used and must be used mostly for clinical trials according to 
2000 Consensus Development Conference. 
 In the trials conducted by Peltoniemi and his co-workers in 2007, 
that allotted 326 women to placebo or 12 mg betamethasone single dose 
rescue treatment. It concluded that the rescue dose increased the risk of 
respiratory distress syndrome. Later the American College of Obstetrics 
and Gynaecologists (2008) too recommends such method for trials. 
 Recently in a study of 437 women, less than 33 weeks who were 
administered rescue therapy or placebo, found that it reduced the rates of 
respiratory complications, and neonatal composite morbidity, with rescue 
corticosteroids according to Kurtzman and co-workers, 2009.  However 
there were nil differences in perinatal mortalities and other morbidities. 
There are also evidences that treated infants had better respiratory 
compliance (Mc Evoy and associates, 2009).  
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PRINCIPLES OF MANAGEMENT IN WOMEN WITH PRETERM 
LABOUR 
1. Steroids to the mother to enhance lung maturity. 
2. Antenatal transfer of the mother to a center equipped with NICU 
3. Tocolytic drugs 
4. Antibiotics 
5. Careful intrapartum monitoring 
6. Vaginal delivery preferred unless cesarean birth is indicated.    
RECOMMENDED MANAGEMENT OF PRETERM LABOUR 
AGE: 34 weeks or more 
MANAGEMENT:  
 Proceed to delivery, usually be initiation of labour 
 Group B streptococcal prophylaxis is suggested 
AGE: 32 weeks to 33 completed weeks 
MANAGEMENT:  
 Expectant management unless fetal pulmonary  maturity is 
documented 
 Group B streptococcal prophylaxis is recommended 
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 Corticosteroids-no consensus, but some experts recommend. 
 Antimicrobials to prolong latency if no contracindications. 
AGE: 24 weeks to 31 completed weeks 
MANAGEMENT 
 Expectant management 
 Group B streptococcal prophylaxis is recommended 
 Single course corticosteroids use is recommended. 
 Tocolytics – no census 
 Antimicrobials to prolong latency if no contraindications. 
AGE: Before 24 weeks 
MANAGEMENT: 
 Patient counselling 
 Expectant management or induction of labor 
 Group B streptococcal prophylaxis is not recommended 
 Corticosteroids use is not recommended. 
 Antimicrobials-There are incomplete data on use in prolonging 
labor. 
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TOCOLYTIC AGENTS 
Tocolysis is pharmacological suppression of uterine activity. 
Tocolytic drugs have been used in an attempt to inhibit preterm 
labour. They are effective in reducing the likelihood of delivery within 48 
hours but do not reduce the overall risk of preterm labour. (ACOG 2007) 
Tocolytics may be required 
1.  To gain 48 hours to administer antenatal steroids for 
increasing pulmonary maturity 
2.  To permit in utero transfer of the patient to a tertiary care 
centre for Multi disciplinary management 
3.  Prepare for neonatal care 
4.  Preparing the patient for an operative delivery 
Variety of drugs which act on uterine smooth muscle to interrupt 
contractions are available these include magnesium sulphate, calcium 
channel blockers, oxytocin antagonists, Non-steroidalanti-inflammatory 
drugs (NSAIDS) and beta mimetic agonists. 
As per ACOG 2003, choice of tocolytic agent is individualized and 
is usually based on the maternal condition. 
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Absolute Contraindications to tocolytic therapy 
 Severe preeclampsia  
 Severe abruption 
 Severe bleeding, any cause  
 Frank chorioamnionitis  
 Foetal death  
 Foetal anomaly incompatible with life  
 Severe foetal growth restriction  
 Mature lung studies  
 Maternal cardiac arrhythmias 
Relative Contraindications to Tocolytic Therapy 
 Mild chronic hypertension  
 Mild abruption 
 Stable previa 
 Maternal cardiac disease  
 Hyperthyroidism  
 Uncontrolled diabetes mellitus  
 Foetal distress  
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 Foetal anomaly  
 Mild intrauterine growth restriction  
 Cervix greater than 4 cm dilated 
 
 SYMPATHOMIMETICS 
Cartis et al noted that small dose of epinephrine inhibited uterine 
hyperactivity .Efforts to produce an epinephrine like compound which 
lacked the cardiovascular stimulant effect culminated in the synthesis of 
beta agonists. 
They react with β adrenergic receptors to reduce intracellular 
ionized calcium levels and prevent activation of myometrial contractile 
proteins Beta mimetics can cause mild fall in diastolic blood pressure and 
isused cautiously in patients of ante partum haemorrhage. They also 
cause a slight increase of blood sugar in non-diabetic patient and hence 
can cause gestational diabetes when used for a longer duration alter 
thyroid function, elevated transaminases hypo calcemia, anti-diuresis and 
hypo kalemia are the other metabolic effects of beta mimetics. 
Some of the neonatal side effects of beta mimetics include 
increased risk of hypo calcemia, hypo glycaemia and interventricular 
haemorrhage. In recent time better drugs have replaced beta mimetics in 
regard to tocolytic function due to better profile of safety and less of 
adverse effects. 
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CLASSIFICATION 
1
st
 Generation: Isoxsuprine, Orciprenaline, Isoprenaline 
2
nd
 Generation: Ritodrine, Terbutaline, Fenoterol 
The most common used beta 2 agonist for tocolysis is ritodrine; 
then is terbutaline and salbutamol. 
RITODRINE 
Merkatz and colleages 1980 achieved a gestational age of 36 weeks 
in patients treated with ritodrine for threatened preterm labour.It is given 
as infusion at a dose of 50 ig/min and increased every 20 minutes until 
uterus is quiescent or side effects limit escalation of dose. 
 However the drugs have been implicated as a cause of 
increased capillary permeability, disturbance of cardiac 
rhythm and myocardial ischemia. 
 Side effects are palpitations, tremor, nausea, headache, chest 
pain dyspnea, pulmonary edema, hypokatemia, myocardial 
ischemia and arrhythmias. 
 Ritodrine was withdrawn voluntarily in 2003, according to 
Federal Register, United States owing to its adverse effects. 
 
 
69 
TERBUTALINE 
Not used as much as ritodrine, but is effective in temporary 
suppression of uterine contractions when given parenterally. 
 intravenous dose 5-10 1g/min ,increased every 10-15 mm to a 
maximum of 80 g. 2.5 — 5 mg is the oral dose given every 4-6 
hours and 250pg subcutaneously every 20-30 minutes given as 4-6 
doses. 
 Terbutaline causes more hyperglycaemia than ritodrine 
Like ritodrine it can cause pulmonary edema (Angel and associates 1988) 
Gunin and associates (1998) reported no significant prolongation 
or improved neonatal outcome with terbutaline is not approved by the 
FDA and therefore it‘s not mentioned in any protocol for pre-term labour. 
Beta 2 agonists are no longer the first choice of drugs because of their 
side effects (RCOG 2002, Anotayanoth et al 2004) 
Contraindications of beta 2 agonist :symptomatic cardiac disease, 
conduction disturbance, hyperthyroidism, sickle cell disease, uncontrolled 
diabetes mellitus, chorioamnionitis, severe preeclarnpsia, multifetal 
gestation and severe obstetrical bleeding. 
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Prostaglandin Inhibitors 
Acetylsalicylate (Aspirin), Indomethacin naproxen fenamate, 
sulindac inhibit prostaglandin syntheses enzyme responsible for the 
transformation of free arachidonic acid to prostaglandins thereby decrease 
the myometrial gap junctions and influx of calcium. 
Indomethacin was first used as a tocolytic by Zuckerman and 
colleagues (1974) various trials compared indomethacin with other drugs 
like ritodrine; Magnesium sulfate and found no difference in efficacy 
(Morales and coworkers (1989, 1193a). 
Indomethacin is administered orally or rectally. A dose of 50 to 
100 mg at 5 hours intervals, not to exceed 200 mg in 24 hours period. 
Adverse effects reported are oligohydramnios, pulmonary 
hypertension due to constriction of ductus arteriosus. Intra cellular 
haemorrhage, necrotizing enterocolitis have also been reported. 
Two randomized trials which compared the effect of indomethacin 
and placebo in delaying delivery showed no significant delay at 48 hours 
and 7 - 10 days. 
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Magnesium sulphate 
Ionic magnesium in a sufficiently high concentration can alter 
myometrial contractility. Its role is presumably that of a calcium 
antagonist causing less intracellular calcium (Ca2+) to participate in 
actins myosin interaction during smooth muscle contraction. Elliott in his 
study found that Magnesium sulphate was effective tocolytic in 87% 
cases. 
Cox and associates in their study did not report any differences in 
the pregnancy outcome using magnesium sulphate. It affects neural 
transmission by modifying acetyl chloline release and sensitivity of motor 
end plate. 
Drug concentration and effect 
 Contractility is inhibited at serum level of 5 - 8 mEq/L. 
 Deep tension reflexes are lost at 9 - 13 mEq/L. 
 Respiratory depression occurs at> 14 Meq/ dl 
Loading dose of 4g IV given over 20 minutes followed by 
maintenance dose of 1-2 g / hour. 
Side effect is nausea, giddiness, flushing, hypocalcemia, 
respiratory depression, pulmonary edema and depressed motor respiratory 
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activity in fetus. Contraindications of magnesium sulfate are myasthenia 
gravis, heart block, renal disease and recent myocardial infarction. 
Neuro protective effect of magnesium sulfate was evaluated in 
(BEAM study-Beneficial Effects of Antenatal Magnesium Sulfate) 
According to Gowther et al 2002, Cochrane systematic review, 
magnesium sulfate is an ineffective tocolytic. Wilkens et al 1989 reported 
the occurrence of significant side effect of magnesium sulphate while 
being used concurrently with beta mimetics for tocolysis. 
CALCIUM CHANNEL BLOCKERS 
These agents act by reducing the influx of calcium ions into the 
cell membrane during the inward calcium current of action potential. 
They block the voltage sensitive L type of calcium channels. They also 
decrease the tone of smooth muscles by inhibition of intracellular calcium 
from sarcoplasmic reticulum .Nifedipine is the most commonly used 
calcium channel blocker. 
King and colleagues 2003, Papatson‘s 1997 concluded that calcium 
channel blockers especially Nifedipine are safer and more effective 
tocolytic agents than are beta agonists and have lower neonatal morbidity 
No significant change in utero placental flow has been reported .Mari et 
al (1989) 
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TREATMENT REGIMEN 
Optimal dose regimen of Nifedipine has not yet been defined. 
George et al 1991, Read and WeIlby (1986), showed that initial dose of 
30 mg followed by 20 mg 8th hourly for 3 days had a success rate of 75% 
Andrenne et al gave a dosing regimen of 30 mg oral followed by a 
maintenance dose of 10 - 20mg orally every 4 - 6 hours. 
Most trials advocated an initial loading dose of 30 mg of oral 
Nifedipine followed by 10 to 20 mg every 6 hours. Sublingual Nifedipine 
is no longer advocated due to risk of sudden hypotension. Onset of action 
is less than 20 minutes with peak plasma concentration within 15 - 90 
minutes. 
Having a half-life of 1.5 to 3 days. Elimination is mainly through 
kidneys (70%) and bowel 30%. Though the duration of action of a single 
dose can be as long as 6 hours, there is no apparent cumulative effect 
when administered every 6 hours. 
Side effects include facial flushing, nausea vomiting, headache, 
hypotension and tachycardia. No significant alteration in blood glucose 
and serum electrolytes was reported. 
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OXYTOCIN ANTAGONIST (ATOSIBAN) 
Nona peptide oxytocin analogy is a competitive antagonist of 
oxytocin induced contractions. 
Dosage 
 Recommended dose and administration schedule is a three step 
procedure. The initial bolus dose is 6.75 mg given over one minute, 
followed by an infusion of 18 mg/hour for three hours and 6 mg/hour for 
up to 45 hours. Treatment should not last longer than 48 hours and total 
dose given should not exceed 330 mg (RCOG, clinical Guidelines 2002) 
Side effects include nausea, vomiting, chest pain, and dyspnoea. 
In randomized clinical trials, artesian failed to improve relevant 
neonatal outcome and was linked with significant neonatal morbidity 
(Moutquin and co-workers, 2000 Romero and associates 2000) 
However, RCOG clinical guidelines 2002 suggested the first 
choice on administration of tocolytic to be oxytocin antagonist or 
Nifedipine. 
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NITRIC OXIDE DONORS (GLYCERYL TRINTRATE) 
It is a potent endogenous hormone having smooth muscle relaxant 
property. Main action affects vasculature, gut and uterus. Nitric oxide 
donors act by inhibiting CRH (Corticotrophin releasing hormone), a 
promoter of parturition. 
Dosage 10 mg Glycerol Tri nitrate patch placed over fundal region 
of maternal abdomen. Dose can be repeated with another 10 mg after one 
hour, if tocolysis is not achieved, to a maximum dose of 20 mg in 24 
hours. Maternal hypotension is a common side effect. 
In randomized clinical trials, Nitro glycerin administered orally, 
transdermal or intravenously was not effective and was no superior to 
other tocolytics (Bistis 2004, Clavin 1996, Rees 1999, Buhimschi 2002. 
DuckittK et al (2002) reported that nitroglycerine did not improve 
neonatal outcome or delay delivery on comparison with placebo, no 
treatment or alternative tocolytics. 
POTASSIUM CHANNEL OPENERS 
Diazoxide is related to thiazide diuretics and its main use is in the 
treatment of malignant hypertension. Its mechanism of action is inhibition 
of smooth muscle contractility, thereby causing uterine quiescence. 
76 
It is given in a dose of 5mg / kg, slow intravenous over 20-30 
minutes. The drug is given after diluting with saline. Bolus dosage 
includes 50 -100 mg given every 5 minutes. 
Side effects are tachycardia, hyperglycaemia, decreased blood 
pressure, and decreased utero placental flow secondary to hypotension in 
the mother. Hypoglycaemia and foetal distress are the side effects which 
occur secondary to maternal hypotension. 
FETAL AND NEONATAL RISKS 
Compromised foetal health is often the precipitating factor in 
threatened or actual preterm labour. Hence, intrauterine foetal death, 
intrauterine growth restriction, major congenital anomalies, unrecognized 
intrauterine infection, and complicated multiple pregnancy will all 
contribute to the perinatal mortality and morbidity rates associated with 
preterm labour. 
RISKS OF PREMATURITY 
The gestational age at which threatened or actual preterm labour   
presents, together with the birth weight, influences both the management 
and the outcome. In women presenting between 20 and 24 weeks' 
gestation, the management decision after discussion with the parents may 
be to allow delivery to occur because of the maternal risks from treatment 
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and the likely poor prognosis for the baby if,  delivery can be postponed 
only for a few hours or days. 
Foetal intrapartum hypoxia and birth trauma associated with 
preterm labour involving the very low birth weight infant, whether birth 
is by the vaginal or abdominal route, will contribute to the perinatal risk. 
The risks in the neonatal period are those of congenital malformation, 
intrauterine growth restriction, respiratory distress syndrome, necrotizing 
enterocolitis, intracranial haemorrhage, convulsions, and septicemia. The 
foetal and neonatal risks associated with the medical management of 
preterm labour have not been accurately quantified, but they require 
consideration in the overall management. 
FETAL RISKS OF TOCOLYTIC AGENTS 
Beta-sympathomimetic tocolytic agents cross the placenta and may 
cause foetal tachycardia and occasionally other adverse foetal cardiac 
effects, which may be significant in an already compromised foetus. The 
maternal hyperglycaemia commonly associated with the use of these 
agents may result in neonatal hypoglycaemia. There is a suggestion that 
neonatal interventricular haemorrhage may be associated with the use of 
oral beta-sympathomimetic drugs, although the data are preliminary. 
There have been only a few small studies of possible long-term ill effects 
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for the neonate, and currently it appears there is no difference in 
developmental outcome. 
Prostaglandin synthetase inhibitors (NSAIDs) cross from the 
mother to the foetus, potentially resulting in prolonged bleeding time, 
cardiopulmonary effects like premature closure or constriction of the 
ductus arteriosus and persistent foetal circulation, renal dysfunction, and 
reduced urinary output. Necrotizing enterocolitis and neonatal intra-
ventricular haemorrhage have also been recorded in association with the 
use of these agents. Most studies have limited the use of prostaglandin 
synthetase inhibitors to short-term therapy (48–72 hours) before 32 to 34 
weeks gestation. Newer and possibly more specific prostaglandin 
synthetase inhibitors such as sulindac, ketorolac, and the COX-2selective 
agents (e.g., nimesulide) are considered to have fewer foetal side effects. 
Magnesium sulfate also readily crosses the placenta and may 
compromise foetal cardiac activity, with reduced baseline variability of 
the foetal heart rate demonstrated by cardio tocography being a common 
association, which in turn may lead to unnecessary intervention. The 
neonate may exhibit hypotonia and hypocalcaemia as a consequence of 
the hypomagnesaemia. The more controversial aspects of magnesium 
sulfate are related to its possible foetal neuro protective role, as several 
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observational studies indicated a reduction in cerebral palsy rate in very 
low birth weight infants in association with its use.  
 
Mitterdorf and associates,, have found in their small randomized 
controlled trial(MagNET trial) that there is a highly significant 
association between tocolytic magnesium sulfate exposure and total 
neonatal mortality rates and worse outcomes in relation to interventricular 
haemorrhage, periventricular leukomalacia, and cerebral palsy. 
Crowther and associates (2003) presented the much larger ACTO 
MgSO4 trial and did not observe an increase in perinatal or neonatal 
mortality rate. A no significant reduction of adverse neurologic sequelae 
was reported.  
Calcium-channel blockers have not been adequately evaluated with 
regard to foetal or neonatal effects, and the Cochrane reviewers 
recommended the assessment of different dose and formulations on 
maternal and neonatal outcomes. Some animal studies have demonstrated 
profound metabolic alterations in the foetus, but these changes have not 
been confirmed in the foetuses of pregnant women. 
Newer tocolytic agents such as nitric oxide donors and oxytocin 
receptor antagonists have not been sufficiently assessed. The maternal 
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administration of thyrotropin-releasing hormone in association with 
corticosteroids was thought, from preliminary studies, to enhance the 
development of foet a llung maturity. The ACTOBAT Study 
demonstrated results to the contrary and hence, its use is discouraged. 
Maternal corticosteroid administration to enhance foetal lung 
maturity is beneficial for the preterm neonate but may carry a number of 
risks, including infection, although the latest available data do not 
confirm this potential complication. These potential risks must be 
balanced against the proven beneficial effect on neonatal pulmonary 
function and the possible reduction in interventricular haemorrhage and 
necrotizing enterocolitis.  
The Dutch trial which studied the effects of maternal prenatal 
corticosteroid administration, suggested a long-term increase in the 
incidence of pharyngeal and ear infections in infants of treated mothers 
but reported no clear evidence of significant foetal or neonatal infection 
in preterm labour associated with intact membranes. The former practice 
of repeated maternal corticosteroid administration encouraged by the NIH 
Consensus Statement (1994) for pregnancies at risk for preterm delivery 
between 24 and34 weeks' gestation is questionable. Crowley and 
associates, in their studies, suggested that there was little evidence of 
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adverse long-term outcomes with repeated maternal corticosteroid 
administration.  
Walfisch and colleagues reviewed 280 articles on this topic and 
concluded that there are no well-designed randomized controlled trials 
(RCTs) in humans that support the advantages of multiple courses over a 
single course of antenatal corticosteroids. 
They also commented that an increasing body of evidence raises 
the concern of adverse consequences from the use of repeated courses. 
This conclusion is consistent with the current Cochrane systematic review 
of three trials. However, fewer infants required surfactant and there were 
fewer cases of severe respiratory distress syndrome (RDS) 
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AIM OF THE STUDY 
This study aims at evaluating phosphorylated cervical insulin like 
growth factor binding protein for the prediction of preterm delivery. This 
is a bed side test for detecting phosphorylated cervical insulin like growth 
factor binding protein from cervical secretion and its value in the 
prediction of preterm delivery. 
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MATERIALS AND METHODS 
The study was conducted in the Dept. Of Obstetrics and 
Gynaecology in Stanley Medical College and Hospital, Chennai over a 
period of December 2013 to September 2014 after getting clearance from 
the ethical committee. The study is a prospective study involving 50 
patients presenting to our hospital with symptoms of preterm labour. 
These included pregnant females with 28-36 weeks of gestation selected 
both outpatient department and casualty. 
Inclusion Criteria 
 Gestational age between 28-36 weeks 
 Regular uterine contractions 
 Intact membranes 
 Cervical dilatation 1 to < 3 cm 
Exclusion Criteria 
 Pregnancy before 28 and after 37 weeks 
 Premature rupture of membranes 
 Bleeding per vagina 
 if they had cervical encirclage 
 had been on tocolysis at admission  
84 
 cervical dilatation of more than3 cm 
 Multiple pregnancies 
 Hypertensive disorders complicating pregnancy 
 Heart disease complicating pregnancy 
 Other maternal and fetal indications requiring termination of 
pregnancy such as intrauterine growth retardation, lethal congenital 
malformations, were also excluded from the study. 
Detailed history and examination of all patients were done. 
Gestational age was calculated based on the last menstrual period and 
confirmed by first trimester or early second trimester ultrasonography.  A 
detailed general systemic and obstetric examination including digital 
cervical assessment after performing the test was done in all cases. 
Performing the Test 
The bedside test kit for pIGFBP-1 is an immuno-enzymatic test 
using monoclonal antibody for detecting antibody specific for the 
phosphorylated form of IGFBP-1. 
Specimen collection 
After explaining the procedure to the patient and getting the 
consent patient is placed in the dorsal position .A sterile speculum is 
introduced into the vagina and the cervical os visualised. A sterile dacron 
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swab was applied over the cervical os and was left approximately for 10-
15 seconds to absorb cervical secretion. 
Extraction of specimen 
The specimen was extracted from the swab by swirling the swab 
vigorously in the tube containing extraction solution for 5- 10 seconds. 
Dipping 
Aluminium foil pouch containing dipstick was opened and the 
yellow testing dip area of stick was placed into tube containing the 
sample and was held until the liquid entered the result area. Dipstick was 
removed from the solution and placed in horizontal position. Result was 
observed in 5 minutes. 
 
Reading the Result 
Positive: When two lines were visible. 
Negative: When only one control line was visible. 
 Absence of distinct control line meant invalid result. 
The test is based on immune-chromatographic qualitative analysis 
of cervical phosphorylated insulin-like growth factor binding proteın-1. 
All cases were administered a course of corticosteroids to enhance 
foetal pulmonary maturation as well as tocolysis as per our departmental 
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protocol. All patients were followed up to delivery. Following delivery, 
data collection about admission to delivery interval was analysed. 
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TABLE: 1  
TEST   AT ADMISSION 
TEST NO.   OF  CASES PERCENTAGE 
POSITIVE 32 64% 
NEGATIVE 18 36 % 
TOTAL 50 100 % 
 
Thirty two women (64%) tested positive for pIGFBP-1 while 
eighteen women (36%) tested negative. 
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TABLE: 2 
Test Result: Delivery Status Crosstabulation 
 
 
 
 
Delivery Status 
Total P value 
Delivered 
Not 
Delivered 
Test 
Result 
Positive Count 30 2 32 
<0.001** 
  
% within 
Test Result 
93.8% 6.3% 100.0% 
  
% within 
Delivery 
Status 
93.8% 11.1% 64.0% 
 Negative Count 2 16 18 
  
% within 
Test Result 
11.1% 88.9% 100.0% 
  
% within 
Delivery 
Status 
6.3% 88.9% 36.0% 
Total Count 32 18 50 
 
% within 
Test Result 
64.0% 36.0% 100.0% 
 
% within 
Delivery 
Status 
100.0% 100.0% 100.0% 
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TABLE: 3 
CORRELATION OF OBSTETRIC STATUS AND TEST 
 
S.NO 
 
OBST.CODE 
 
DELIVERED/NOT 
DELIVERED 
 
NO OF 
CASES 
 
PERCENTAGE 
1. PRIMI +ve DELIVERED 18 100% 
NOT DELIVERED 0 - 
2. PRIMI -ve DELIVERED 0 - 
NOT DELIVERED 7 100% 
3. MULTI +ve DELIVERED 12 85.71% 
NOT DELIVERED 2 14.29% 
4. MULTI -ve DELIVERED 2 18.18% 
NOT DELIVERED 9 81.82% 
 
Among the 18 primigravida patients with a positive test, all 18 
delivered and the 7 primigravida women with a negative test, none of 
them delivered. 
Among the 14 multigravida patients with a positive test, 12 
delivered and the 11 multigravida women with a negative test, 2 of them 
delivered. 
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TABLE: 4 
CORRELATION OF CONTRACTIONS AND TEST 
CONTRACTIONS TESTS TOTAL NO. DELIVERED 
NOT 
DELIVERED 
2-3 
CONTRACTIONS 
POSITIVE 3 2 1 
NEGATIVE 18 2 16 
3-4 
CONTRACTIONS 
POSITIVE 29 28 1 
NEGATIVE _ _ _ 
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TABLE: 5 
CORRELATION CERVICAL DILATATION AND TEST 
 
CERVICAL 
DILATATION 
TESTS 
TOTAL 
NO. 
DELIVERED 
NOT 
DELIVERED 
1F POSITIVE 14 14 - 
NEGATIVE 6 - 6 
2cm POSITIVE 18 16 2 
NEGATIVE 12 2 10 
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TABLE: 6 
Correlation of Gestation Age and Test Result 
PERIOD OF 
GESTATION 
IN WEEKS 
POSITIVE NEGATIVE 
NO PERCENTAGE NO PERCENTAGE 
28-30 8 25.1 5 27.78 
30-32 4 12.5 5 50 
32-34 11 34.38 7 22.22 
34-36 9 28.12 1  
TOTAL 32 100 18 100 
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TABLE: 7 
 CORRELATION OF TEST TO DELIVERY INTERVAL 
(POSITIVE TEST) 
TEST TO DELIVERY 
TIME INTERVAL 
POSITIVE  TEST 
NO. PERCENTAGE 
<2 DAYS 19 63.34 % 
2-7  DAYS 10 33.33% 
>7  DAYS 1 03.33% 
TOTAL 30 100% 
 
In patients with positive test 19 delivered within 48 hrs, 10 
delivered within 2-7 days and 1 delivered after 7 days. 
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TABLE: 8 
CORRELATION OF TEST TO DELIVERY INTERVAL 
(NEGATIVE TEST) 
TEST TO 
DELIVERY TIME 
INTERVAL 
NEGATIVE TEST 
NO. PERCENTAGE 
<7 DAYS 5 31.25 % 
Up to 7  DAYS 11 68.75% 
TOTAL 16 100% 
 
In patients with negative test 11 patients did not deliver up to 7 
days and 5 patients continued pregnancy beyond 7 days.  Only two 
patients who had a negative test delivered prematurely. 
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RESULT 
A total of 50 women were selected for the study. The range of 
gestational age was between 28 and 36 weeks. Thirty two women (64%) 
tested positive for pIGFBP-1 while eighteen women (36%) tested 
negative. All the patients received antenatal steroids and tocolytic therapy 
according to our hospital protocols.  
Among the 32 patients with a positive test, only 2 delivered at term 
and the other 30 patients delivered preterm (<37 weeks). Among the 18 
women with a negative test, only two delivered preterm. 
Among the 18 primigravida patients with a positive test, all 18 
delivered and the 7 primigravida women with a negative test, none of 
them delivered. 
Among the 14 multigravida patients with a positive test, 12 
delivered and the 11 multigravida women with a negative test, 2 of them 
delivered. In patients with positive test 19 delivered within 48 hrs, 10 
delivered within 2-7 days and 1 delivered after 7 days. 
In patients with negative test 11 patients did not deliver up to 7 
days and 5 patients continued pregnancy beyond 7 days.  Only two 
patients who had a negative test delivered prematurely. 
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DISCUSSION 
Preterm delivery and birth remains a major concern of obstetric 
practice. It is the second leading cause of neonatal mortality and 
morbidity. Unfortunately, many tests are not available to diagnose 
preterm labour precisely. A physiologic marker for the onset of preterm 
birth is the presence and frequency of the uterine contractions and 
cervical dilatation. However, this finding alone is not predictive of 
preterm delivery. As the accurate diagnosis of preterm labour is not so 
simple many false-positive diagnosis have been made. 
In our study 32 women (64%) tested positive for PIGFBP-1, while 
18 women (36%) tested negative. Among the 32 patients with a positive 
test, only 2 delivered at term and the other 30 patients delivered preterm 
(<37 weeks). Among the 18 women with a negative test, only two 
delivered preterm (p < 0.05). 
The positive predictive value of the test is 93.75% and the negative 
predictive value is 88.89%. The p value was <0.001. 
The women who tested negative for IGFBP-1 had a significantly 
shorter stay in the hospital. The result shows that the bedside test for 
PIGFBP-1 has a sensitivity of 93.8% and a specificity of 88.9% for the 
prediction of preterm delivery before 36 weeks. 
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 In the study rapid diagnostic test for prediction of preterm delivery 
by actimpartus kit in Department of Obstetrics and Gynaecology, Hi Tech 
Medical College, Utkal University, Bhubaneshwar, India 94 patients were 
recruited. Positive was 28 and negative was 60 .Admission to delivery 
interval in weeks was 2.3 and 5.1 respectively. The P value was <0.001 
and significant. 
In another prospective cohort study conducted in the Dept. of 
Obstetrics and Gynaecology, SN Medical College and Hospital, Agra, 
included pregnant females with 28-36 weeks of gestation .Fifty cases 
were included in this study. A positive result was associated with 
significantly reduced admission-to-delivery interval. The median 
admission-to-delivery interval was 3.25 days in the group with positive 
PIGFBP-1 results while 6.97 days with a negative PIGFBP-result (p < 
0.001). Sensitivity, specificity, positive predictive value and negative 
predictive value of Actimpartus test is 72.22%, 90.6% 81.25% and 
85.29%, respectively. 
 In studies of Kwek et al, 47 women suspected preterm labour 
between 23 and 33 weeks were taken and bedside test for IGFBP-1 was 
performed. Twenty-nine women (61.7%) tested negative and 18 women 
tested positive (38.3%). In addition, 91.7% of the patients in the IGFBP-1 
negative group had a delay of more than 7 days between the onset of 
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contractions and delivery, while only 44.4% of the women in the 
pIGFBP-1 positive group experienced such a delay. The result shows that 
the bedside test for PIGFBP-1 has a sensitivity of 87.37% and a 
specificity of 82.6% for the prediction of preterm delivery before 36 
weeks. The positive predictive value of the test is 77.8% and the negative 
predictive value is 79.2%. 
In a study conducted by Elizur, et al, mean gestational age at 
delivery in patients testing positive for beside test for PIGFBP-1 was 36.2 
± 2.4 weeks (p value 0.001).  
The result shows that bedside test for PIGFBP-1 has a sensitivity of 
87.37% and a specificity of 82.6% for the prediction of preterm delivery 
before 36 weeks. 
The positive predictive value of the test is 77.8% and the negative 
predictive value is 79.2%. 
 Lembet et al, conducted a prospective study on 36 women 
between 20 and 36 weeks of gestation with regular contractions. Eighteen 
patients had a positive beside test for PIGFBP-1 and 18 had a negative 
test. Among the 18 patients with a positive test, only one delivered at 
term and the other 17 patients delivered preterm (<37 weeks). Among the 
18 women with a negative test, two delivered preterm (p < 0.05). 
105 
Sensitivity, specificity, positive and negative predictive values of the 
rapid PIGFBP-1 test for preterm delivery were 89.5%, 94.1%, 94.4% and 
88.9%, respectively. 
In study of Ting et al 108 patients were recruited into the study. 
Patients tested negative for PIGFBP-1, the median (± standard deviation 
[SD]) gestational age delivery was 37.4 weeks (± 1.8 weeks) and in 
positive PIGFBP-1 the median gestational age at delivery was 32.9 weeks 
(± 4.0 weeks). The p value was <0.001.  
Based on this discussion it can be concluded that results are 
comparable for beside test for PIGFBP-1. This test has very reasonable 
accuracy and easy to use 
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SUMMARY 
Preterm labour is a significant factor affecting perinatal outcomes, 
in terms of complications and mortality. Preterm labour is the onset of 
labour before 37 weeks of gestation birth. 
About 40-45% of preterm labour occurs spontaneously and 30% 
because of rupture of membranes (preterm), and the rest 30-35% are 
induced preterm labours. Infection is one of the most common cause of 
preterm labour and responsible for 20-40% of all preterm cases. preterm 
labour is established when regular uterine contractions occur at least 4 in 
20 minutes or 8 in 60 minutes with progressive change in cervical score 
with effacement 80% or more and dilatation more than 1 cm occurs. 
Preterm labour can be diagnosed by various factors .Preterm labour can 
be diagnosed by clinical methods and by investigations. 
Diagnosis of preterm labour poses a major problem. Any test that 
can precisely diagnose preterm labour will be of much help. One of the 
latest modality in predicting preterm labour is phosphorylated insulin like 
growth factor binding protein -1 in cervical secretions. The maternal 
concentration of insulin like growth factor binding protein 1 increases as 
pregnancy advances and forms a major constituent of amniotic fluid from 
second trimester onwards. 
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During the process of labour, the choriodecidual interface is 
disrupted releasing the phosphorylated insulin like growth factor binding 
protein -1 into the cervical secretions. Bed side kits have been developed 
for the qualitative detection of phosphorylated insulin like growth factor 
binding protein -1    above 10mg/l.  
Our study was a prospective study. A total of 50 women were 
selected for the study. Swabs were  placed in the cervix and left for 5- 10 
seconds in patients with preterm  labour.The swab was placed into a 
diluent and shaken vigorously for 5-10 seconds. The dip stick provided in 
the kit was placed in the diluent till the diluent gets absorbed. The dip 
stick was placed horizontally on the table and observed for the results. 
 Test is based on immune chromatographic qualitative analysis of 
cervical phosphorylated insulin-like growth factor binding proteın-1.  
If 2 lines appear the test was considered as positive and if single 
line appeared the test was considered as negative. Test positive and 
negative cases were followed up for 2 weeks whether patient delivered or 
not. All the patients received antenatal steroids and tocolytic therapy 
according to our hospital protocols 
 
The range of gestational age was between 28 and 36 weeks. In our 
study 32 women (64%) tested positive for PIGFBP-1, while 18 women 
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(36%) tested negative. Among the 32 patients with a positive test, only 2 
delivered at term and the other 30 patients delivered preterm (<37 weeks). 
Among the 18 women with a negative test, only two delivered preterm (p 
< 0.05). 
The positive predictive value of the test is 93.75% and the negative 
predictive value is 88.89%. The p value was <0.001. 
 
The women who tested negative for IGFBP-1 had a significantly 
shorter stay in the hospital. The result shows that the bedside test for 
PIGFBP-1 has a sensitivity of 93.8% and a specificity of 88.9% for the 
prediction of preterm delivery before 36 weeks. 
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CONCLUSION 
 
Cervical phosphorylated insulin like growth factor binding protein 
-1 alone is a useful tool for predicting women who are at risk for pre-term 
delivery. It is a rapid bedside immune enzymatic test. It is an easy, lucid, 
faster, convenient method of predicting preterm labour and exclusion of 
premature labour and delivery in symptomatic women. The test is easy 
one step rapid dip stick test and can be done by any health worker 
clinicians, nurses, or laboratory technicians in both urban and rural 
settings  and does not need expertise opinion.  
It is less expensive. With symptomatic patients a negative test 
result is a clear indication that the delivery will not start within the next 7 
days. Cervical phosphorylated insulin like growth factor binding protein -
1 has a higher negative predictive value of 1 in predicting risk of delivery 
within 48 hrs. If facilities available, this can be combined with 
measurement of cervical length and this will further increase the 
predictive value   in predicting pre-term delivery in symptomatic women. 
It will allow us to focus on women who are more likely to deliver 
preterm and timely in utero referral to higher centres equipped with 
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neonatal resusitation and preterm care. It also helps us avoid unnecessary 
referral and treatment and to curtail health care burden and costs. 
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 IP NO:                                                   EDD: 
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MENSTRUAL  HISTORY :                            MD SINCE: 
OBSTETRIC HISTORY: 
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HT:                        WT:                 TEMP:                        PR:                             BP: 
PALLOR:                                            PEDAL EDEMA: 
CVS:                                               RS: 
P/A:                                                                                 CONTRACTIONS: 
P/V: 
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HB:                        RBS:                           U/A:  
USG: 
CERVICAL SWAB TEST : 
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STAY IN HOSPITAL: 
 
OUTCOME: 
 
  
  
RESULT: 
 
 
 
 
 
123 
CONSENT FORM 
I agree to participate in the study entitled ‗EVALUATION OF 
PREDICTION OF PRETERM LABOUR USING CERVICAL 
PHOSPHORYLATED INSULIN LIKE GROWTH FACTOR BINDING 
PROTEIN‖ 
I confirm that I have been told about this study in my mother tongue and 
have had the opportunity to clarify my doubts. 
I understand that my participation is voluntary and I may refuse to 
participate at any time without giving any reasons and without affecting 
my benefits. 
I agree not to restrict the use of any data or results that arise from this 
study. 
 
Name of the participant: 
Sign / Thumb print: 
Sign of Investigator: 
124 
 
125 
 
126 
 
127 
 
128 
 
129 
 
130 
 
131 
 
 
